![](/img/cover-not-exists.png)
Addition of Epigallocatechin Gallate 400 mg to Sofosbuvir 400 mg + Daclatisvir 60 mg With or Without Ribavirin in Treatment of Patients with Chronic Hepatitis C Improves the Safety Profile: A Pilot Study
Shiha, Gamal, Soliman, Reham, Elbasiony, Mohamed, Darwish, Noureldien H. E., Mousa, Shaker A.Volume:
9
Language:
english
Journal:
Scientific Reports
DOI:
10.1038/s41598-019-49973-6
Date:
December, 2019
File:
PDF, 1.03 MB
english, 2019